Eyconis | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

276 results for “Eyconis”

Trials

View all 267 →

EyeConic: Qualification for Cone-Optogenetics

1,000 participants · First posted Mar 24, 2022

Histopathological Changes in Mycosis Fungoides

10 participants · First posted Jun 15, 2023

Early Diagnosis of Mycosis Fungoides

620 participants · First posted Sep 3, 2015

Drugs

sEHI (EicOsis)

CTAT-ADC(EUCODIS Bioscience)

Organizations

EicOsis Human Health, Inc.

United States

News

Eyconis Initiates First-in-Human Trial of Long-Acting Anti-VEGF Therapy EYC-0305 in Treatment-Naïve Wet AMD

Ascendis Pharma Reports Strong 2025 Performance with €720M Revenue and Advances TransCon Pipeline

Advanced Mycosis Fungoides Treatment Requires Strategic Sequencing of HDAC Inhibitors and Targeted Therapies

Page 1 of 28